InvestorsObserver
×
News Home

Antares Pharma Inc (ATRS) Stock: Do Analysts Think You Should Accumulate?

Wednesday, November 17, 2021 02:29 PM | InvestorsObserver Analysts

Mentioned in this article

Antares Pharma Inc (ATRS) Stock: Do Analysts Think You Should Accumulate?

InvestorsObserver is giving Antares Pharma Inc (ATRS) an Analyst Rating Rank of 74, meaning ATRS is ranked higher by analysts than 74% of stocks. The average price target for ATRS is $6.571 and analyst’s rate the stock as a Strong Buy.

Overall Score - 5
Wall Street analysts are rating ATRS a Strong Buy today. Find out what this means to you and get the rest of the rankings on ATRS!

Why are Analyst Ratings Important?

Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve. InvestorsObserver combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.

What's Happening With Antares Pharma Inc Stock Today?

Antares Pharma Inc (ATRS) stock is trading at $3.46 as of 2:13 PM on Wednesday, Nov 17, a loss of -$0.09, or -2.4% from the previous closing price of $3.54. The stock has traded between $3.45 and $3.56 so far today. Volume today is below average. So far 319,473 shares have traded compared to average volume of 642,677 shares. Click Here to get the full Stock Report for Antares Pharma Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App